{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent investigations have revealed a potential regulatory role for the microRNA miR‐5692a in hepatocellular carcinoma (HCC), one of the world’s most prevalent and deadly cancers due to its often late diagnosis and limited treatment options. In this study, researchers focused on elucidating the underlying mechanisms by which miR‐5692a may contribute to HCC progression. The findings suggest that miR‐5692a is involved in the modulation of signaling pathways that affect cell proliferation and invasion, thereby potentially promoting a more aggressive tumor phenotype. These insights underscore the promise of miR‐5692a as both a diagnostic biomarker for early HCC detection and a target for therapeutic intervention, potentially leading to improved clinical outcomes in HCC patients."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Shijie Sun, Ning Wang, Ziwen Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-5692a promotes proliferation and inhibits apoptosis by targeting HOXD8 in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J BUON (2019)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30941968"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30941968"}]}]}]}